The Effect of the Nutraceutical Hemofix on the Coagulation System

Phase 1 Study of the Nutraceutical Hemofix Safety and Effect on the Coagulation System

Status

Withdrawn

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01651468

Enrollment

Registered

2012-07-27

Start date

2016-09-30

Completion date

2023-12-31

Last updated

2017-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menorrhagia, Von Willebrand Disease

Keywords

mild bleeding disorder

Brief summary

Hemofix is a herbal formula based on traditional Jewish and far eastern medicine created to assist in wound healing and bleeding arrest. It contains herbs such as Red Clover, Liquorice, Raspberry, Ginger and more. The present study will evaluate the formula on the coagulation system.

Interventions

DIETARY_SUPPLEMENTHEMOFIX

unique complex herbal mixture

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Yes

Inclusion criteria

* Healthy volunteers and volunteers with a mild bleeding disorder

Exclusion criteria

* people with thrombophilic and cardiovascular complications, * people who are treated with anti-coagulants, * women taking birth control pills * people with a history hypercoagulability

Design outcomes

Primary

Measure	Time frame
bleeding and blood test results	one year

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026